Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Mylan Looks To Expedite Biosimilar Humira in EU Through Kyowa Deal

Apr 12 2018

• By Anju Ghangurde and Ian Haydock

3d render of Europe map Earth globe — MYLAN GAINS EU RIGHTS TO BIOSIMILAR HUMIRA

Related Content

The New 180 Days? Humira Biosimilar Deals Give Amgen 150-Day Jump On Samsung

Apr 06 2018

Related Companies

Viatris Inc.

FUJIFILM Holdings Corp.

Biocon, Ltd.

AbbVie Inc.

Additional Topics

India Asia Pacific Europe Commercial BioPharmaceutical

More from India

More from Focus On Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window